by Sharon O'Reilly
The musculoskeletal sector continues to be bogged down by the economic downturn, and particularly hard hit is the industry's largest segment—the $13 billion total joint market. Acroßs the board, leading total joint manufacturers (Biomet Inc., DePuy Synthes/Johnson & Johnson, Smith & Nephew Inc./Smith & Nephew PLC, Stryker Corp., Wright Medical Technology Inc./Wright Medical Group Inc., and Zimmer Spine/Zimmer Biomet Holdings Inc.) report that implant prices continue to soften and procedural volumes remain slow
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?